Magda.N.A.Nasr
Mansoura University
H-index: 18
Africa-Egypt
Top articles of Magda.N.A.Nasr
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Targeting carbonic anhydrases II/IX/XII with novel series of coumarin-based compounds: Synthesis, biological activity and molecular dynamics analysis | Journal of Molecular Structure | Fiby N Takla Sumera Zaib Waleed A Bayoumi Kiran Shehzadi Shahenda M El-Messery | 2024/3/15 |
Benzimidazole based hybrids as privileged candidates for topoII inhibition: Design, synthesis and molecular modeling studies | Journal of Molecular Structure | Nareman A Nawareg Amany S Mostafa Shahenda M El-Messery Magda NA Nasr | 2024/2/15 |
Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling study | Scientific Reports | Fiby N Takla Waleed A Bayoumi Shahenda M El-Messery Magda NA Nasr | 2023/8/17 |
Insights into modulating the monastrol scaffold: Development of new pyrimidinones as Eg5 inhibitors with anticancer activity | Archiv der Pharmazie | Mohamed G Thabit Amany S Mostafa Khalid B Selim Magda AA Elsayed Magda NA Nasr | 2022/10 |
Synthesis and Biological Evaluation of 2, 4-Diaminoquinazolines as Potential Antitumor Agents | Chemistry & Biology Interface | Pathan Sultan Ismail Irfan Khan Vivek Kumar Kashyap Ved Prakash Verma Monika Shukla | 2019 |
New benzimidazole based hybrids: synthesis, molecular modeling study and anticancer evaluation as TopoII inhibitors | Bioorganic Chemistry | Nareman A Nawareg Amany S Mostafa Shahenda M El-Messery Magda NA Nasr | 2022/10/1 |
Design, synthesis and molecular modeling of phenyl dihydropyridazinone derivatives as B-Raf inhibitors with anticancer activity | Bioorganic Chemistry | Mohamed G Thabit Amany S Mostafa Khalid B Selim Magda AA Elsayed Magda NA Nasr | 2020/10/1 |
Synthesis, biological evaluation and molecular modeling study of [1, 2, 4]-Triazolo [4, 3-c] quinazolines: New class of EGFR-TK inhibitors | Journal of Medicinal Chemistry | Dan Du Jun Yan Jinhong Ren Haining Lv Yong Li | 2013/1/10 |
